Psyched Wellness to Present at the Psychedelic Investment Series on Monday, May 31, 2021

Toronto, Ontario, May 12, 2021 – Psyched Wellness Ltd. (CSE:PSYC, OTCQB:PSYCF, FRANKFURT:5U9) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company will be participating in the upcoming Psychedelic Capital virtual event.

Psyched will be presenting at the next edition of the psychedelic investment series on Monday, May 31, 2021 at 1:30 PM EST.

The Psychedelic Capital Investment Conference is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe.

Each month, the #PsyCap features the top companies, latest IPOs, newest opportunities, and deepest insights into the emerging psychedelic space. Investment thought leaders and wealth influencers provide our audiences with valuable insights. C-suite company executives covering every corner of the psychedelics industries, media and financial services companies are available to speak one on one. This is a must-attend for investors.

For more information and/or to register for the conference please visit:

“I look forward to participating in this event with my director, Terry Booth. PsyCap has done a great job attracting top companies in the sector and we appreciate the opportunity to introduce Psyched Wellness to their investing audience.” says Jeffrey Stevens, CEO of the Company.